Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians

This study has been completed.
Information provided by:
University of Hawaii Identifier:
First received: January 10, 2005
Last updated: July 2, 2013
Last verified: July 2009

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.

Cardiovascular Diseases
Heart Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians

Resource links provided by NLM:

Further study details as provided by University of Hawaii:

Estimated Enrollment: 276
Study Start Date: September 2004
Study Completion Date: August 2011
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Participants will be a Native Hawaiian or Pacific Islander (e.g., Samoan, Tongan, Tahitian, Maori, Marshallese, etc.)


Inclusion Criteria:

  • Clinical symptoms and signs of heart failure AND

    1. Left ventricular systolic ejection fraction of less than 40% OR
    2. Left ventricular systolic ejection fraction of less than 60% AND evidence of abnormal diastolic function confirmed by echocardiogram and documented in the patient's medical record
  • Discharged from a hospital admission for heart failure as a primary or secondary discharge diagnosis within 6 weeks of study entry
  • Self-identified ethnicity/race as Native Hawaiian or Pacific Islander (e.g., Samoan, Tongan, Tahitian, Maori, Marshallese, etc.)

Exclusion criteria

  • Heart failure caused by high-output states (i.e., sepsis, etc.) or transient non-cardiac disease
  • Terminal illnesses in addition to heart failure (e.g., cancer with projected survival of less than 6 months)
  • Currently living in a nursing home
  • Currently undergoing hemodialysis or peritoneal dialysis
  Contacts and Locations
Please refer to this study by its identifier: NCT00101465

United States, Hawaii
University of Hawaii at Manoa
Honolulu, Hawaii, United States, 96822
Queen's Medical Center
Honolulu, Hawaii, United States, 96813
Sponsors and Collaborators
University of Hawaii
Principal Investigator: Marjorie Mau University of Hawaii at Manoa
Principal Investigator: Todd Seto Queen's Medical Centre
  More Information

No publications provided

Responsible Party: Nobumi Nakamura, University of Hawaii at Manoa Identifier: NCT00101465     History of Changes
Other Study ID Numbers: 1281, U01HL079163, U01 HL79163
Study First Received: January 10, 2005
Last Updated: July 2, 2013
Health Authority: United States: Federal Government

Keywords provided by University of Hawaii:
Heart Failure

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Heart Failure processed this record on April 17, 2014